ALNY
Alnylam Pharmaceuticals, Inc.
Stock
$219.72−11.46 (−4.96%)Close Oct 2, 2026
- Free cash flow, 2025
- $465M
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $465M | — |
| 2024 | −$43M | — |
| 2023 | $42M | — |
| 2022 | −$613M | — |
| 2021 | −$718M | — |
| 2020 | −$685M | — |
| 2019 | −$419M | — |
| 2018 | −$690M | — |
| 2017 | −$487M | — |
| 2016 | −$372M | — |
| 2015 | −$202M | — |
| 2014 | −$175M | — |
| 2013 | −$73M | — |
| 2012 | −$124M | — |
| 2011 | −$88M | — |
| 2010 | −$89M | — |
| 2009 | −$77M | — |
| 2008 | $55M | — |